Chemo-radiotherapy in locally advanced squamous cell oesophageal cancer-are upper third tumours more esponsive?

Pathology and Oncology Research

Volumn 16, Issue 2, 2010, Pages 193-200

  Papp, Andras ^a   Cseke, Laszlo ^a   Farkas, Robert ^a   Pavlovics, Gabor ^a   Horvath, Gabor ^b   Varga, Gabor ^a   Szigeti, Andras ^a   Bellyei, Szabolcs ^a   Marton, Sandor ^a   Poto, Laszlo ^a   Kalmar, Katalin ^a   Vereczkei, Andras ^a   Pozsgai, Eva ^a   Horvath, Ors Peter ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Johns Hopkins Medicine International   (United Arab Emirates)

Author keywords

Complete response; Locally advanced tumor; Neoadjuvant therapy; Squamous cell oesophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINATE CALCIUM;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNGECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PREOPERATIVE TREATMENT; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 77955717357     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9206-5     Document Type: Article

References (27)

1. Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux Ph, Van Raemdonck D (2001) Cancer of the esophagus and gastroesophageal junction: potentially curative therapies Surg Oncol 10:113-122
2. Keighley MRB (2003) Gastrointestinal cancers in Europe. Aliment Pharmacol Ther 18(Suppl. 3):7-30
3. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 234(3):360-367 discussion 368-9
4. Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J (2003) Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg. 238(3):339- 347 discussion 347-8
5. P. Sorrentino et al. (1988) Prognostic Significance of Tumor Stage and Lymph Node Involvement in Thoracic Esophageal Cancer. In: J.R. Siewert, A.H.Hölscher (ed) Diseases of the esophagus Springer-Verlag Berlin Heidelberg, pp:709-713,
6. Piessen G, Mariette C, Triboulet JP (2005) Cervical and upperthird thoracic oesophageal carcinoma: a single pathological entity? Ann Chir. 130(2):86-91
7. Feinstein AR (1985) Clinical epidemiology. Saunders, Philadelphia
8. Horvath OP, Cseke L, Kalmar K, Varga G, Horvath G (2001) Larynx-preserving pharyngo-esophagectomy after chemoradiation in the treatment of cancer of the pharyngo-esophageal junction. Ann Thorac Surg. 72(6):2146-2147
9. Pavlovics G, Cseke L, Papp A, Tizedes G, Tabar BA, Horvath PO (2006) Esophagus reconstruction with free jejunal transfer. Microsurgery 26(1):73-77
10. Wong R, Malthaner R (2003) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localised carcinoma of the esophagus (Cochrane Review), in the Cochrane Library, Issue 1. Oxford, Update Softwer
11. Mariette C, Piessen G, Triboulet JP (2007) Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 8:545-553
12. El Nakadi I, Van Laethem JL, Houben JJ, Gay F, Closset J, Van Houtte P, Danhier S, Limbosch JM, Lambilliotte JP, Gelin M (2002) Squamous cell carcinoma of the esophagus: multi- modal therapy in locally advanced disease. World J Surg 26 (1):72-78
13. Meneu-Diaz JC, Blazquez LA, Vicente E, Nuno J, Quijano Y, Lopez-Hervas P, Devesa M, Fresneda V (2000) The role of multimodality therapy for resectable esophageal cancer. Am J Surg 179(6):508-513
14. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, Sahmoud T (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337(3):161-167
15. Visser BC, Venook AP, Patti MG (2003) Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. Surg Oncol 12(1):1-7
16. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185(6):538-543
17. Kaklamanos IG, Walker GR, Ferry K, Franceschi D (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10:754-761
18. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD (2005) Neoadjuvant chemoradiotherapy for esophageal carcinoma:a metaanalysis. Surgery 137:172-177
19. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226-234
20. Urba SG, Orringer MB, Turrisi A et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305-313
21. Berger AC, Farma J, Scott WJ et al. (2005) Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23:4330-4337
22. Saito R, Suzuki H, Motoyama S, Sasaki S, Okuyama M, Ogawa J, Kitamura M (2000) A clinical study of surgical treatment of patients with carcinoma of the cervical esophagus extending to the thoracic esophagus. Jpn J Thorac Cardiovasc Surg 48(7):417-423
23. Peracchia A, Bonavina L, Botturi M, Pagani M, Via A, Saino G (2001) Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esoph 14:95-97
24. Liebermann-Meffert DM, Luescher U, Neff U, Rüedi TP, Allgöwer M (1987) Esophagectomy without thoracotomy: is there a risk of intramediastinal bleeding? A study on blood supply of the esophagus. Ann Surg 206(2):184-192
25. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H (2005) Chemoradiation with and whitout surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23(10):2310-2317
26. Bedenne L, Michel P, Bouche O et al. (2002) Randomised phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol 21:130a abstr 519
27. Burmeister B, Dickie G, Smithers B, Hodge R, Morton K (2000) Thirty-four patients with carcinoma of the cervical esophagus treated with chemoradiation therapy. Arch Otolaryngol Head Neck Surg 126:205-208